Table 1.
Descriptive statistics of the 4 phases of aspirin research.
| Phases, Time span | Number of publications | Number of authors | Average number of authors | Number of journals | |||||
| 1. Original use |
|
|
|
|
|||||
|
|
1951-1955 | 208 | 318 | 1.76 | 117 | ||||
| 1956-1960 | 299 | 498 | 1.88 | 159 | |||||
| 1951-1960 | 507 | 794 | 1.83 | 218 | |||||
| 2. In-depth studies of pharmacological mechanisms and side effects |
|
|
|||||||
|
|
1961-1965 | 748 | 1310 | 2.01 | 301 | ||||
| 1966-1970 | 1268 | 2167 | 2.12 | 418 | |||||
| 1971-1975 | 2766 | 4880 | 2.40 | 696 | |||||
| 1976-1980 | 3797 | 7419 | 2.71 | 895 | |||||
| 1981-1985 | 4395 | 10,011 | 3.16 | 1033 | |||||
| 1986-1990 | 4470 | 11,600 | 3.50 | 1101 | |||||
| 1961-1990 | 17,444 | 31,787 | 2.90 | 2153 | |||||
| 3. Repurposing for cardiovascular diseases |
|
|
|||||||
|
|
1991-1995 | 5164 | 14,044 | 3.69 | 1256 | ||||
| 1996-2000 | 6353 | 17,694 | 4.10 | 1314 | |||||
| 1991-2000 | 11,517 | 28,818 | 3.91 | 1798 | |||||
| 4. Repurposing for other diseases |
|
|
|||||||
|
|
2001-2005 | 8099 | 27,784 | 4.22 | 1719 | ||||
| 2006-2010 | 9366 | 35,313 | 4.94 | 1974 | |||||
| 2011-2015 | 10,436 | 44,603 | 5.78 | 2410 | |||||
| 2016-2018 | 6018 | 30,796 | 6.73 | 1881 | |||||
| 2001-2018 | 33,919 | 118,857 | 5.33 | 3865 | |||||
| Total | 63,387 | 171,559 | 4.39 | 5443 | |||||